https://peptidereferee.com/alerts/ Closures, raids, warning letters and other events affecting research peptide vendors. en https://peptidereferee.com/alerts/#2026-10-injectify-closing 2026-10-injectify-closing Thu, 15 Oct 2026 12:00:00 GMT On October 15, 2026, Injectify's homepage said the business was "closing soon" and advertised a closing-down discount. Its US store was still listing products when we checked; the notice gave no closing date. https://peptidereferee.com/alerts/#2026-10-pure-rawz-stops-selling 2026-10-pure-rawz-stops-selling Thu, 15 Oct 2026 12:00:00 GMT By October 15, 2026, purerawz.co described itself as "an informational and affiliate website" that does "not sell or directly supply the products featured on this website". Its peptide pages now link to other vendors with a discount code instead of selling. https://peptidereferee.com/alerts/#2026-09-biov8-tga-court-action 2026-09-biov8-tga-court-action Mon, 28 Sep 2026 12:00:00 GMT The TGA announced that the former company and directors behind BioV8, an Australian online peptide seller, will face court over alleged unlawful advertising of peptides. These are allegations; the court hasn't ruled. https://peptidereferee.com/alerts/#2026-09-chameleon-peptides-closure 2026-09-chameleon-peptides-closure Sun, 27 Sep 2026 12:00:00 GMT Chameleon Peptides' storefront says it is closed for new purchases, with a sign-in archive left open so existing customers can view order history and lab reports. A review site dates the closure to September 27, 2026; an archived capture from September 20, 2026 shows the shop still operating. https://peptidereferee.com/alerts/#2026-08-tex-peptides-warning-letter 2026-08-tex-peptides-warning-letter Mon, 24 Aug 2026 12:00:00 GMT FDA reviewed texpeptide.com in July 2026 and classed semaglutide, tirzepatide, retatrutide, SS-31, tesamorelin, PT-141 and bacteriostatic water products as unapproved new drugs. It cited bacteriostatic water marketed for reconstituting the products as evidence of intended human use. https://peptidereferee.com/alerts/#2026-08-royal-peptides-warning-letter 2026-08-royal-peptides-warning-letter Mon, 24 Aug 2026 12:00:00 GMT FDA reviewed royal-peptides.com in July 2026 and classed its tirzepatide, semaglutide, retatrutide, SS-31, PT-141, tesamorelin and 'BIMORELIN' products as unapproved new drugs. It said bacteriostatic water sold alongside a 'peptide guide' and 'peptide calculator' showed the products were intended for human use. https://peptidereferee.com/alerts/#2026-08-peptide-partners-warning-letter 2026-08-peptide-partners-warning-letter Mon, 24 Aug 2026 12:00:00 GMT FDA reviewed peptide.partners in July 2026 and classed its semaglutide, tirzepatide, retatrutide, SS-31, tesamorelin and bremelanotide (PT-141) products, and a bacteriostatic water 'Reconstitution Solution', as unapproved new drugs. https://peptidereferee.com/alerts/#2026-08-peak-performance-peptides-warning-letter 2026-08-peak-performance-peptides-warning-letter Mon, 24 Aug 2026 12:00:00 GMT FDA reviewed pppepz.com in July 2026 and classed bacteriostatic water, 'GLP-3R' (retatrutide), semaglutide, SS-31, PT-141 and tesamorelin as unapproved new drugs, rejecting 'research use only' and 'not for human consumption' labels. https://peptidereferee.com/alerts/#2026-08-nuscience-peptides-warning-letter 2026-08-nuscience-peptides-warning-letter Mon, 24 Aug 2026 12:00:00 GMT FDA reviewed nusciencepeptides.com in July 2026 and classed products including 'GLP-1 Sema', 'GLP-2 Tirz', 'GLP-3 RT (Retatrutide)', survodutide, mazdutide, PT-141, tesamorelin and bacteriostatic water as unapproved new drugs, rejecting 'for laboratory, research, and analytical use' labels. https://peptidereferee.com/alerts/#2026-08-lilly-retatrutide-lawsuits 2026-08-lilly-retatrutide-lawsuits Wed, 12 Aug 2026 12:00:00 GMT Eli Lilly announced lawsuits against Aesthetic Envy Cosmetic Centers, Astra, Legendary Peptides, Striker Pharmacy, Texas Peptides and Lone Star Peptide over sales of retatrutide, its unapproved investigational drug. Lilly alleges some sellers labeled the drug 'research use only' while selling it for human use. https://peptidereferee.com/alerts/#2026-08-tga-nsw-influencer-seizure 2026-08-tga-nsw-influencer-seizure Tue, 04 Aug 2026 12:00:00 GMT With NSW Police, the TGA executed search warrants at two New South Wales properties and seized more than $120,000 of peptide and steroid products, including retatrutide, CJC-1295 and a BPC-157 and TB-500 blend, allegedly imported, relabelled and sold online by an influencer the TGA had previously warned. https://peptidereferee.com/alerts/#2026-07-paradigm-peptides-sentencing 2026-07-paradigm-peptides-sentencing Thu, 30 Jul 2026 12:00:00 GMT The owner of Paradigm Peptides (Paradigm R.E. LLC), which sold peptides, hCG and products labeled as SARMs online, was sentenced to 5 years and 10 months in federal prison; a company employee received 1 year and 4 months. Both pleaded guilty on December 10, 2025. Investigators found that many products sold as SARMs contained testosterone. https://peptidereferee.com/alerts/#2026-07-strate-labs-closure 2026-07-strate-labs-closure Tue, 28 Jul 2026 12:00:00 GMT By July 28, 2026, stratelabs.com showed a notice that the company had permanently closed because the regulatory landscape had shifted in ways that made it impossible to continue operating as before. The notice said pending orders would ship as scheduled. https://peptidereferee.com/alerts/#2026-07-fda-pcac-peptide-votes 2026-07-fda-pcac-peptide-votes Thu, 23 Jul 2026 12:00:00 GMT The FDA's Pharmacy Compounding Advisory Committee voted 8-6 with one abstention in favor of BPC-157 for compounding; trade press reported the same tally for KPV and TB-500 and 7-5 with two abstentions for MOTS-c, against the views of FDA staff scientists. The votes are non-binding, and formal rulemaking is needed before pharmacies may compound these peptides. https://peptidereferee.com/alerts/#2026-07-tga-peptide-promoters-on-notice 2026-07-tga-peptide-promoters-on-notice Mon, 20 Jul 2026 12:00:00 GMT The TGA warned that suppliers and promoters of unapproved peptide products, including influencers, affiliates and online sellers, may face warning letters, infringement notices, seizures, civil penalties and, in serious cases, prosecution. It said it is working with social media and e-commerce platforms to remove unlawful advertising. https://peptidereferee.com/alerts/#2026-06-wholesale-peptide-warning-letter 2026-06-wholesale-peptide-warning-letter Wed, 17 Jun 2026 12:00:00 GMT FDA reviewed wholesalepeptide.com in May 2026 and classed its Prostamax and gonadorelin products as unapproved new drugs, noting that injectable products bypass some of the body's key defences against toxins and microorganisms. https://peptidereferee.com/alerts/#2026-06-tga-peptide-compliance-priority 2026-06-tga-peptide-compliance-priority Wed, 10 Jun 2026 12:00:00 GMT Australia's TGA added unapproved peptide products to its compliance priority areas after increased unlawful importation, supply and advertising. It cited a joint operation with Australian Border Force and Victoria Police that seized peptides, performance and image enhancing drugs and steroids worth more than $2 million. https://peptidereferee.com/alerts/#2026-05-mhra-northamptonshire-raid 2026-05-mhra-northamptonshire-raid Thu, 28 May 2026 12:00:00 GMT MHRA officers raided a property near Northampton believed to be used to make and distribute unlicensed weight-loss medicines, including retatrutide and tirzepatide, as well as peptide products. They recovered about 12,000 doses of unlicensed weight-loss medicines and arrested two men on suspicion of offenses under the Human Medicines Regulations 2012. https://peptidereferee.com/alerts/#2026-04-fda-peptides-withdrawn-from-category-2 2026-04-fda-peptides-withdrawn-from-category-2 Wed, 22 Apr 2026 12:00:00 GMT As of its April 22, 2026 update, the FDA's page on bulk drug substances with significant safety risks lists BPC-157, TB-500, CJC-1295, KPV, MOTS-c and other peptides under 'bulk drug substances nominated but withdrawn' (previously category 2). GHRP-2, GHRP-6 and kisspeptin-10 remain in category 2. None of these peptides is in category 1. https://peptidereferee.com/alerts/#2026-04-health-canada-ruo-advisory 2026-04-health-canada-ruo-advisory Thu, 09 Apr 2026 12:00:00 GMT Health Canada warned consumers against injectable peptides bought online and said 'For Research Use Only – Not for Human Consumption' labeling does not make products legal or exempt from regulatory requirements. It said it is working with the Canada Border Services Agency to stop unauthorized shipments. https://peptidereferee.com/alerts/#2026-04-amino-asylum-domain-change 2026-04-amino-asylum-domain-change Thu, 02 Apr 2026 12:00:00 GMT Amino Asylum is no longer trading. An archived capture from April 2, 2026 shows aminoasylum.com redirecting to ww1.aminoasylum.com, a pattern typical of domain-parking services. Widely repeated reports of a June 2025 FDA raid could not be confirmed against any FDA, Department of Justice or court record. https://peptidereferee.com/alerts/#2026-03-gram-peptides-warning-letter 2026-03-gram-peptides-warning-letter Tue, 31 Mar 2026 12:00:00 GMT FDA reviewed grampeptides.com from January to March 2026 and found retatrutide (sold as 'GLP-1-R peptide'), tirzepatide ('GLP-2 peptide') and bacteriostatic water for injection for sale. It rejected 'Research Use Only' labels and classed the products as unapproved new drugs. https://peptidereferee.com/alerts/#2026-03-peptide-sciences-closure 2026-03-peptide-sciences-closure Sun, 08 Mar 2026 12:00:00 GMT By March 8, 2026, Peptide Sciences' homepage carried a notice that the company had decided to voluntarily shut down operations and discontinue the sale of its research products. The notice gave no reason. https://peptidereferee.com/alerts/#2026-02-mhra-lincolnshire-nottinghamshire-raids 2026-02-mhra-lincolnshire-nottinghamshire-raids Wed, 25 Feb 2026 12:00:00 GMT The MHRA announced raids on a farm near Sleaford and a home in Grantham believed to be used to make and distribute unlicensed weight-loss medicines, including retatrutide and tirzepatide, as well as peptide products. Officers seized almost 2,000 doses awaiting dispatch. https://peptidereferee.com/alerts/#2026-02-science-bio-closure 2026-02-science-bio-closure Sun, 08 Feb 2026 12:00:00 GMT By February 8, 2026, Science.bio's homepage said it had permanently closed; an archived capture from January 7, 2026 still shows the shop. Its current notice warns that any website, entity or individual claiming to be Science.bio or its successor is fraudulent. https://peptidereferee.com/alerts/#2025-12-rize-fitness-health-canada 2025-12-rize-fitness-health-canada Wed, 24 Dec 2025 12:00:00 GMT Health Canada seized unauthorized health products from Rize Fitness in Vancouver, which also sold them online. They included injectable peptides sold under the PHX Labs name, such as semaglutide, AOD-9604, CJC-1295, epithalon and GHK-Cu. https://peptidereferee.com/alerts/#2025-10-mhra-northampton-raid 2025-10-mhra-northampton-raid Fri, 24 Oct 2025 12:00:00 GMT The MHRA's Criminal Enforcement Unit raided a Northampton warehouse it described as the UK's first illicit weight-loss medicine production facility. Officers seized more than 2,000 unlicensed retatrutide and tirzepatide pens awaiting dispatch, along with tens of thousands of empty pens and raw ingredients. https://peptidereferee.com/alerts/#2025-08-canada-peptide-health-canada 2025-08-canada-peptide-health-canada Fri, 01 Aug 2025 12:00:00 GMT Health Canada said it seized unauthorized injectable peptide drugs from Canada Peptide, which sold them through its website. The affected products include BPC-157, CJC-1295, retatrutide and tirzepatide among dozens of others; none is authorized for sale in Canada. https://peptidereferee.com/alerts/#2025-04-prime-research-health-canada 2025-04-prime-research-health-canada Mon, 14 Apr 2025 12:00:00 GMT Health Canada seized unauthorized injectable peptide drugs and bodybuilding drugs sold online by Prime Research of Sherbrooke, Quebec. At Health Canada's request, the company stopped advertising and selling the products and took down its website. https://peptidereferee.com/alerts/#2025-02-usa-peptide-warning-letter 2025-02-usa-peptide-warning-letter Wed, 26 Feb 2025 12:00:00 GMT FDA said usapeptide.com was introducing unapproved and misbranded semaglutide and tirzepatide products into interstate commerce, and warned that drugs which circumvent regulatory safeguards may be contaminated, counterfeit, or contain varying or different ingredients. https://peptidereferee.com/alerts/#2024-12-xcel-peptides-warning-letter 2024-12-xcel-peptides-warning-letter Tue, 10 Dec 2024 12:00:00 GMT FDA reviewed xcelpeptides.com in October 2024 and found retatrutide, cagrilintide, a cagrilintide and semaglutide product, mazdutide, semaglutide, survodutide and sermorelin for sale. It rejected 'For research use only' and 'Not intended for human use' labels and classed the products as unapproved new drugs. https://peptidereferee.com/alerts/#2024-12-swiss-chems-warning-letter 2024-12-swiss-chems-warning-letter Tue, 10 Dec 2024 12:00:00 GMT FDA reviewed swisschems.is and the seller's Facebook and Instagram accounts in October 2024 and found semaglutide and retatrutide for sale. It said 'research chemicals only' labeling did not change its finding that the products are unapproved new drugs. https://peptidereferee.com/alerts/#2024-12-summit-research-peptides-warning-letter 2024-12-summit-research-peptides-warning-letter Tue, 10 Dec 2024 12:00:00 GMT FDA reviewed summitpeptides.shop and the seller's Facebook page in October 2024 and found semaglutide, retatrutide, cagrilintide, tirzepatide and mazdutide for sale. It classed the products as unapproved new drugs. https://peptidereferee.com/alerts/#2024-12-prime-peptides-warning-letter 2024-12-prime-peptides-warning-letter Tue, 10 Dec 2024 12:00:00 GMT FDA reviewed primepeptides.co and the seller's social media in October 2024 and found semaglutide and retatrutide for sale. It rejected 'research purposes only' and 'not for human consumption' labels and classed the products as unapproved new drugs. https://peptidereferee.com/alerts/#2024-06-quad-inc-health-canada-advisory 2024-06-quad-inc-health-canada-advisory Wed, 26 Jun 2024 12:00:00 GMT Health Canada warned consumers not to buy unauthorized injectable peptide drugs from quadragen.io and advancedresearch.bio, websites associated with Quad Inc. A July 19, 2024 update added nootropic drops and an RU-58841 topical product found among the products seized from the company. https://peptidereferee.com/alerts/#2024-02-us-chem-labs-warning-letter 2024-02-us-chem-labs-warning-letter Wed, 07 Feb 2024 12:00:00 GMT FDA reviewed uschemlabs.com in October 2023 and found semaglutide, tirzepatide and thymalin offered as 'research chemicals only'. It classed the products as unapproved new drugs and misbranded drugs. https://peptidereferee.com/alerts/#2024-02-helix-chemical-supply-warning-letter 2024-02-helix-chemical-supply-warning-letter Wed, 07 Feb 2024 12:00:00 GMT FDA reviewed helixchem.com in October 2023 and found semaglutide and tirzepatide for sale alongside health claims and dosing schedules. It said 'research use only' and 'not for human consumption' labels did not change its finding that the products are unapproved new drugs and misbranded drugs. https://peptidereferee.com/alerts/#2023-06-warrior-labz-warning-letter 2023-06-warrior-labz-warning-letter Mon, 12 Jun 2023 12:00:00 GMT FDA reviewed warriorlabzsarms.com in May 2023 and found BPC-157 (injectable and nasal spray), TB-500 and SARMs for sale. It said 'research purpose only' and 'not for human consumption' labels did not change its finding that the products are unapproved new drugs.